Source: FierceBiotechIT

Adimab: Adimab swaps scientist for lawyer as CEO Tillman Gerngross steps down after 15 years

Adimab swaps scientist for lawyer as CEO Tillman Gerngross steps down after 15 years jwaldron Tue, 05/10/2022 - 08:38

Read full article »
Adimab's Competitors | Adimab's News | Adimab's Financials
Stay up-to-date with the latest news on Adimab
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Philip T. Chase's photo - CEO of Adimab

CEO

Philip T. Chase

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Adimab